News

Designed to facilitate and advance the use of complex adaptive, Bayesian, and other novel clinical trial designs, the program provides an opportunity for sponsors to interact with experts from FDA.

Businessman hands connecting puzzle pieces representing the merging of two companies or joint venture, partnership, Mergers and acquisition concept. | Image credit: © Worawut-stock.adobe.com

Signant Acquires DSG

Signant adds DSG’s solution suite to its own capabilities to grow CRO and sponsor services.

In this Q&A, Craig Serra, head of commercial solutions and partnerships within the clinical research business unit at Flatiron Health (affiliate of the Roche Group), shares his perspective on clinical research, the role of data, and Flatiron Health’s efforts to that end.